We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
A greyscale headshot of Iain Yisu Wang
Credit: Iain Yisu Wang

Iain Yisu Wang, PhD profile page

Product Manager

 at MedChemExpress

Dr. Iain Yisu Wang is a UK-based Product Manager at MedChemExpress, specialising in small-molecule reagents and screening platforms. He leads new product development, market and competitor analysis and technical product support.
He holds a PhD in Bioscience (Cardiff), an MSc in Pharmacology (Oxford) and a BSc in Biochemistry (Bristol), backed by several years of academic and industry experience across developmental biology, cancer research and diagnostics. He has co-authored multiple peer-reviewed publications.


Education

Cardiff University  

University of Oxford  

University of Bristol  


Areas of Expertise

Developmental Biology
Cancer Research
Diagnostics

Got a Question for Iain Yisu Wang, PhD?

Get in touch using the contact form linked here and we'll get back to you shortly.



Content Written By, Reviewed By, or Featuring Iain Yisu Wang, PhD
Total: 3
Illustration of scientists in purple lab coats working together on an experiment.
Article

How Is Collaboration Driving Life Science Innovation?

Where do the greatest opportunities for collaboration across life sciences disciplines lie today – and what’s needed to unlock them? We asked the experts.
Five scientists in white lab coats standing looking at a camera with their arms folded.
Article

What One Change Does Life Sciences Need? We Asked the Experts

What single change could most accelerate progress across the field? We asked leading researchers, innovators and policy experts to share their perspectives.
Magnifying glass highlighting a yellow capsule among various blue and white pills during drug screening.
Industry Insight

From Hits to Leads: Improving Early Drug Discovery With Better Tools

In this interview, Dr. Iain Yisu Wang from MedChemExpress discusses the growing role of AI, the value of phenotypic screening and how tailored compound libraries are helping researchers keep up with the increasing complexity of drug discovery.
Advertisement
Advertisement
Advertisement
Decoratvive background images
Never miss a story
with the Breaking Science News daily newsletter